becomes partners with ZenBio to speed up drug discovery

| By | Drug Development, R&D
263, the life science industry’s leading online marketplace for outsourced research, announced a partnership with ZenBio, Inc., an industry leader in delivering custom cell-based solutions to speed drug discovery and development.

Earlier, in July, the marketplace entered a pertnership with HealthEconomics, the community that links global stakeholders in the real-world evidence (RWE).

Users can now easily find and access human skin tissue online to aid in cosmetic screening, primary skin cell assays and skin tests, among other custom research services. is the world’s leading marketplace for outsourced research. The marketplace simplifies the entire research sourcing process, saving time and money and providing access to the latest innovative tools and technologies while maintaining full compliance with an organization’s procurement policies.

Founded in 1995, ZenBio, is the industry leader in robust cell-based solutions to accelerate the discovery and development of therapies to better the human condition. The ZB mission is to provide the highest quality cells, reagents and contract services to the global biomedical research, pharmaceutical and biotechnology communities within the study of human metabolic disease. ZB pioneered tissue engineering with adult adipose-derived stem cells and is currently expanding its product offering to include extracellular vesicles as novel biological response modifiers. ZenBio is a privately held biotechnology company, located in Research Triangle Park (Durham, North Carolina, USA) and has extensive worldwide distribution through a network of technically experienced partners.

GMP news
Pharmaceutical industry News and events. Technology transfer and contract manufacturing of medicines.